Introduction to Smoking Cessation
Smoking is one of the biggest avoidable causes of morbidity and mortality worldwide and is a significant burden to healthcare systems. Tobacco dependence is a chronic, relapsing condition driven by addiction to nicotine, and smoking cessation may require repeated interventions and long-term support. Two groups are involved in cessation strategies: policy makers, through banning sales and advertising; and healthcare providers, through behavioural counselling, nicotine replacement products, and drugs such as bupropion. However, only a small portion of smokers who try to quit succeed, and only a minority use any proven aids that will increase their chances of success.
Smoking Cessation Content
The Challenges of Smoking Cessation
touchREVIEWS in Respiratory. 2022;7(1):4–5
Smoking is one of the biggest avoidable causes of morbidity and mortality worldwide and is a significant burden to healthcare systems. Without intervention, the annual total of 7.69 million deaths and 200 million disability-adjusted life-years caused by smoking are likely to increase over the coming decades.1 Several smoking cessation interventions have proven to be effective; however, […]
Hiroki Tateno – Novel CureApp for smoking cessation
At the American Thoracic Society meeting, Dr Hiroki Tateno shared the results of a randomized, sham-controlled, open-label study to evaluate the long-term efficacy of CureApp, a novel smoking cessation app (CureApp Inc.), when used in addition to pharmacotherapy. Questions 1. What smoking cessation aids are currently available and how successful have they been in achieving […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!